Shree Ganesh Biotech (India) Limited
BSE: SHREEGANES · Biotechnology
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Shree Ganesh Biotech (India) Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Shree Ganesh Bio-Tech India Limited is an agribusiness company focused on the production, processing, and marketing of hybrid seeds for cereals, pulses, and vegetables. The company utilises tissue culture and advanced breeding techniques to enhance crop yields and pest resistance.
Business Model
The company generates revenue through the sale of hybrid seeds and agricultural inputs, supplemented by the trading of agricultural commodities and the production of organic fertilisers.
Management Commentary
Management is focused on diversifying revenue streams and expanding the company's distribution network across various Indian states to meet the rising demand for organised agri-inputs.
Growth Outlook
Growth is expected to be driven by the expansion of the distribution network and the continued adoption of scientific seed development techniques to improve agricultural productivity.
Key Risks
- Climatic Dependency. The company's performance is highly sensitive to unpredictable weather patterns and monsoon cycles which directly impact crop yields and seed demand.
- Regulatory Risk. Changes in government policies regarding agricultural inputs, seed pricing, and biotechnology regulations could adversely affect operations.
- Market Competition. As a micro-cap entity, the company faces significant competition from larger, well-capitalised players in the Indian seed and agribusiness sector.
- Operational Scale. The company's relatively small scale may limit its ability to absorb market shocks or invest heavily in large-scale research and development.
Start your research today
Unlock AI insights, financials, peers and live data on Shree Ganesh Biotech (India) Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹5 Cr
TTM · standalone
NET PROFIT
₹0.81 Cr
TTM · standalone
EPS
₹0.02
TTM · standalone
RETURN ON EQUITY
1.3%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
3.8%
TTM · standalone
P/E
23.5x
Q4 FY26 · standalone
EV/EBITDA
23.6x
Q4 FY26 · standalone
EBITDA MARGIN
16.3%
TTM · standalone
NET PROFIT MARGIN
7.1%
Q4 FY26 · standalone
DEBT TO EQUITY
0.0x
Q4 FY26 · standalone
Peers · Biotechnology
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Shree Ganesh Biotech (India) LimitedSHREEGANES | ₹19 Cr | 23.50 | 23.60 | -78.4% | 16.3% | 1.3% | 3.8% | -39.0% |
Anthem Biosciences Ltd.ANTHEM | ₹49,668 Cr | 124.56 | 52.01 | — | 47.5% | 18.9% | 25.4% | +11.0% |
Advanced Enzyme Technologies LimitedADVENZYMES | ₹3,326 Cr | 18.51 | 12.33 | 12.2% | 35.0% | 11.3% | 14.3% | -17.3% |
As of Q4 FY26
Financials
Shree Ganesh Biotech (India) Limited
BSE: SHREEGANES · Biotechnology
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Shree Ganesh Biotech (India) Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Shree Ganesh Bio-Tech India Limited is an agribusiness company focused on the production, processing, and marketing of hybrid seeds for cereals, pulses, and vegetables. The company utilises tissue culture and advanced breeding techniques to enhance crop yields and pest resistance.
Business Model
The company generates revenue through the sale of hybrid seeds and agricultural inputs, supplemented by the trading of agricultural commodities and the production of organic fertilisers.
Management Commentary
Management is focused on diversifying revenue streams and expanding the company's distribution network across various Indian states to meet the rising demand for organised agri-inputs.
Growth Outlook
Growth is expected to be driven by the expansion of the distribution network and the continued adoption of scientific seed development techniques to improve agricultural productivity.
Key Risks
- Climatic Dependency. The company's performance is highly sensitive to unpredictable weather patterns and monsoon cycles which directly impact crop yields and seed demand.
- Regulatory Risk. Changes in government policies regarding agricultural inputs, seed pricing, and biotechnology regulations could adversely affect operations.
- Market Competition. As a micro-cap entity, the company faces significant competition from larger, well-capitalised players in the Indian seed and agribusiness sector.
- Operational Scale. The company's relatively small scale may limit its ability to absorb market shocks or invest heavily in large-scale research and development.
Start your research today
Unlock AI insights, financials, peers and live data on Shree Ganesh Biotech (India) Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹5 Cr
TTM · standalone
NET PROFIT
₹0.81 Cr
TTM · standalone
EPS
₹0.02
TTM · standalone
RETURN ON EQUITY
1.3%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
3.8%
TTM · standalone
P/E
23.5x
Q4 FY26 · standalone
EV/EBITDA
23.6x
Q4 FY26 · standalone
EBITDA MARGIN
16.3%
TTM · standalone
NET PROFIT MARGIN
7.1%
Q4 FY26 · standalone
DEBT TO EQUITY
0.0x
Q4 FY26 · standalone
Peers · Biotechnology
As of Q4 FY26